Sollis Therapeutics
Columbus
About Sollis Therapeutics
Sollis Therapeutics is a clinical-stage specialty pharmaceutical company developing novel non-steroid, non-opioid analgesics. Sollis’ first product is an extended-release combination analgesic and anti-inflammatory drug designed for local delivery for the treatment of sciatica and other neuropathic pain syndromes. The company was founded in 2017 and is headquartered in Columbus, Ohio.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $52.5M
- Last round: Debt Financing (Mar 2021)
- Website: sollistx.com
Industries & Categories
Biotechnology, Medical, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/sollis-therapeutics-83019 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.